Clinical Trial Update: Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial [NA]

View source ↗

Summary

The LUMEN1 trial evaluating leflunomide in MEN1 patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Endocrine Neoplasia Type

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: MEN1 Gene Mutation | NA | Status: TERMINATED